Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Bre
ClinicalTrials.gov study NCT04915755. IPD Sharing: YES. Countries: 27. Publications: 0.
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT01964924. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT00887575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Re-expression of ER in Triple Negative Breast Cancers
ClinicalTrials.gov study NCT01194908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04345913. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04373031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccination of Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02938442. IPD Sharing: NO. Countries: 1. Publications: 0.
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
ClinicalTrials.gov study NCT02315196. IPD Sharing: NO. Countries: 1. Publications: 0.
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01111825. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
ClinicalTrials.gov study NCT04683679. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03310957. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02730130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05843292. IPD Sharing: NO. Countries: 0. Publications: 28.
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04177108. IPD Sharing: YES. Countries: 37. Publications: 0.
Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04958785. IPD Sharing: NO. Countries: 6. Publications: 0.
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05113966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer
ClinicalTrials.gov study NCT00371254. IPD Sharing: Not stated. Countries: 4. Publications: 0.
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01918306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
ClinicalTrials.gov study NCT01849250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT02595138. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.